VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-0.88%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.79M
Cap. Flow %
-2.99%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

1
XFLT
XAI Octagon Floating Rate and Alternative Income Trust
XFLT
$663K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
$469K
4
EFT
Eaton Vance Floating-Rate Income Trust
EFT
$425K
5
ENIC icon
Enel Chile
ENIC
$406K

Top Sells

1
GRA
W.R. Grace & Co.
GRA
$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
$693K
4
NOA
North American Construction
NOA
$569K
5
MCI
Barings Corporate Investors
MCI
$524K

Sector Composition

1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SNDX icon
251
Syndax Pharmaceuticals
SNDX
$1.47B
$215K 0.09%
11,241
-594
-5% -$11.4K
ESPR icon
252
Esperion Therapeutics
ESPR
$540M
$214K 0.09%
17,773
-1,625
-8% -$19.6K
MGNX icon
253
MacroGenics
MGNX
$126M
$214K 0.09%
10,213
-541
-5% -$11.3K
RXDX
254
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$214K 0.09%
9,043
-476
-5% -$11.3K
ETNB icon
255
89bio
ETNB
$1.32B
$213K 0.09%
10,877
-565
-5% -$11.1K
LXRX icon
256
Lexicon Pharmaceuticals
LXRX
$396M
$213K 0.09%
44,378
-2,321
-5% -$11.1K
NVAX icon
257
Novavax
NVAX
$1.28B
$213K 0.09%
1,028
-49
-5% -$10.2K
IMAB
258
I-MAB
IMAB
$358M
$212K 0.09%
2,925
-161
-5% -$11.7K
DTIL icon
259
Precision BioSciences
DTIL
$59.8M
$211K 0.09%
610
-32
-5% -$11.1K
ITOS
260
DELISTED
iTeos Therapeutics
ITOS
$209K 0.09%
7,731
-403
-5% -$10.9K
STRO icon
261
Sutro Biopharma
STRO
$89.9M
$209K 0.09%
11,067
-577
-5% -$10.9K
ARVN icon
262
Arvinas
ARVN
$575M
$208K 0.09%
2,530
-125
-5% -$10.3K
MRUS icon
263
Merus
MRUS
$5.1B
$207K 0.09%
9,391
-485
-5% -$10.7K
CRIS icon
264
Curis
CRIS
$21M
$206K 0.09%
1,317
-69
-5% -$10.8K
VIR icon
265
Vir Biotechnology
VIR
$732M
$203K 0.09%
4,664
-248
-5% -$10.8K
GRCL
266
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$203K 0.09%
14,608
-755
-5% -$10.5K
FMTX
267
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$203K 0.09%
8,759
-461
-5% -$10.7K
RNA icon
268
Avidity Biosciences
RNA
$6.48B
$202K 0.09%
8,189
-424
-5% -$10.5K
GERN icon
269
Geron
GERN
$893M
$201K 0.09%
146,618
-7,649
-5% -$10.5K
KRTX
270
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$201K 0.09%
1,644
-84
-5% -$10.3K
IMCR icon
271
Immunocore
IMCR
$1.87B
$199K 0.09%
5,359
-275
-5% -$10.2K
PHAT icon
272
Phathom Pharmaceuticals
PHAT
$875M
$197K 0.09%
6,150
-326
-5% -$10.4K
PRLD icon
273
Prelude Therapeutics
PRLD
$69.6M
$197K 0.09%
6,292
-330
-5% -$10.3K
COGT icon
274
Cogent Biosciences
COGT
$1.82B
$196K 0.09%
23,335
-1,219
-5% -$10.2K
FDMT icon
275
4D Molecular Therapeutics
FDMT
$340M
$196K 0.09%
7,257
-385
-5% -$10.4K
9 10
11
12 13